Preventative effects of rosiglitazone on restenosis after coronary stent implantation in patients with type 2 diabetes.

OBJECTIVE Despite the popularity of coronary stenting in coronary artery disease (CAD), restenosis remains a challenging clinical problem. This study evaluated the efficacy of rosiglitazone for preventing in-stent restenosis in type 2 diabetic patients. RESEARCH DESIGN AND METHODS We conducted a prospective, randomized, case-controlled trial involving 95… CONTINUE READING